Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Optos PLC

BioPhotonics
Jul 2006
Optos PLC of Dunfermline, UK, has received FDA approval for its P200MA retinal imaging device. The instrument, which takes a quarter of a second to scan approximately 80 percent of the retina, is expected to aid in the detection of glaucoma, diabetes and high blood pressure, among other diseases. The technology is already being tested in the US.

BiophotonicsBusinessRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.